摘要

250 adverse reactions of Swissmedic-authorized veterinary medicinal products were reported during the year 2013 (2012: 197). Similar to previous years, most of the reactions reported were linked to the use of antiparasitic products (46.4%) or antiinfectives (12.4%). 8.4% of the reports described reactions after reconverted use, mainly in cats. Species concerned were primarily dogs (144 reports), cats (53) and cattle or calves (40). Additionally, 46 reports were generated during consulting by the Swiss Toxicological Information Centre in Zurich. We present a series of serious cases following the use of prostaglandin derivatives in dairy cows and reactions caused by a newly authorized antiparasitic drug for dogs containing amitraz. Finally, the vaccinovigilance program received 160 declarations following the application of various vaccines, mainly to dogs or cats.

  • 出版日期2014-11